Carles A

References (3)

Title : Fluoroethylnormemantine (FENM) shows synergistic protection in combination with a sigma-1 receptor agonist in a mouse model of Alzheimer's disease - Freyssin_2023_Neuropharmacol__109733
Author(s) : Freyssin A , Carles A , Guehairia S , Rubinstenn G , Maurice T
Ref : Neuropharmacology , :109733 , 2023
Abstract : Freyssin_2023_Neuropharmacol__109733
ESTHER : Freyssin_2023_Neuropharmacol__109733
PubMedSearch : Freyssin_2023_Neuropharmacol__109733
PubMedID: 37844867

Title : Dual-Acting Small Molecules: Subtype-Selective Cannabinoid Receptor 2 Agonist\/Butyrylcholinesterase Inhibitor Hybrids Show Neuroprotection in an Alzheimer's Disease Mouse Model - Spatz_2023_J.Med.Chem__
Author(s) : Spatz P , Steinmuller SAM , Tutov A , Poeta E , Morilleau A , Carles A , Deventer MH , Hofmann J , Stove CP , Monti B , Maurice T , Decker M
Ref : Journal of Medicinal Chemistry , : , 2023
Abstract : Spatz_2023_J.Med.Chem__
ESTHER : Spatz_2023_J.Med.Chem__
PubMedSearch : Spatz_2023_J.Med.Chem__
PubMedID: 37127287

Title : Photoswitchable Pseudoirreversible Butyrylcholinesterase Inhibitors Allow Optical Control of Inhibition in Vitro and Enable Restoration of Cognition in an Alzheimer's Disease Mouse Model upon Irradiation - Scheiner_2022_J.Am.Chem.Soc__
Author(s) : Scheiner M , Sink A , Hoffmann M , Vrigneau C , Endres E , Carles A , Sotriffer C , Maurice T , Decker M
Ref : Journal of the American Chemical Society , : , 2022
Abstract : Scheiner_2022_J.Am.Chem.Soc__
ESTHER : Scheiner_2022_J.Am.Chem.Soc__
PubMedSearch : Scheiner_2022_J.Am.Chem.Soc__
PubMedID: 35138833